Analgesics in Portugal
Euromonitor International's Analgesics in Portugal market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 45 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Systemic analgesics; Topical analgesics/anaesthetic
Table of contents
OTC HEALTHCARE IN PORTUGAL : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC healthcare achieves continued positive retail value growth in 2008
Ageing population and self-medication boost demand for OTC healthcare
Trend of self-medication benefits popular brands
Increased distribution promotes growth of OTC healthcare
Constant value growth of OTC healthcare to remain positive
KEY TRENDS AND DEVELOPMENTS
Economic crisis hampers growth of some categories of OTC healthcare
Ageing population, a key driver of demand for products in OTC healthcare
Self-medication, an accelerator of growth of OTC healthcare
Smoking ban boosts demand for products in NRT smoking cessation aids
Competition between distribution channels positively impacts OTC healthcare
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
MARKET INDICATORS
Table 3 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 4 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 5 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 6 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 7 OTC Healthcare Company Shares by Value 2004-2008
Table 8 OTC Healthcare Brand Shares by Value 2005-2008
Table 9 Penetration of Private Label by Sector 2003-2008
Table 10 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 11 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 12 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 13 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Table 14 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 15 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 16 OTC Healthcare Company Shares by Value 2004-2008
Table 17 OTC Healthcare Brand Shares by Value 2005-2008
Table 18 Penetration of Private Label by Sector 2003-2008
Table 19 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 20 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 21 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 22 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - PORTUGAL
DERMOTECA-PRODUTOS QUIMICOS E DERMATOLOGICOS SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Dermoteca-Produtos Quimicos e Dermatologicos SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Dermoteca-Produtos Quimicos e Dermatologicos SA: Competitive Position 2008
GRUNENTHAL SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Grunenthal SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Laboratórios Andrómaco SA: Competitive Position 2008
LABORATORIO J NEVES, LDA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Laboratorio J Neves Lda: Key Facts
Summary 7 Laboratorio J Neves Lda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Laboratorio J Neves Lda: Competitive Position 2008
LABORATóRIO MEDINFAR PRODUTOS FARMACêUTICOS SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Laboratório Medinfar Produtos Farmacêuticos SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Laboratório Medinfar Produtos Farmacêuticos SA: Competitive Position 2008
NEO-FARMACêUTICA, LDA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Neo-Farmacêutica Lda: Key Facts
Summary 12 Neo-Farmaceutica Lda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Neo-Farmacêutica Lda: Competitive Position 2008
PEISFAR SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Peisfar SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Peisfar SA: Competitive Position 2008
ANALGESICS IN PORTUGAL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 23 Sales of Analgesics by Subsector: Value 2003-2008
Table 24 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 25 Herbal vs Standard Topical Analgesics 2003-2008
Table 26 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 27 Analgesics Company Shares by Value 2004-2008
Table 28 Analgesics Brand Shares by Value 2005-2008
Table 29 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 30 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013